Printer-FriendlySAN ANTONIO, TX (May 6, 2013) – About half of all women over age 50 and 1 in 4 men will break a bone due to osteoporosis. Yet the disease, which causes bones to become fragile and more likely to fracture, remains poorly understood, according to osteoporosis expert Dr. Sol Epstein.
Press Releases
Get up-to-date news from Mission Pharmacal Company and find out about our new products, recent announcements from Mission, and our latest innovations.
Click on any of the links to read the release. For older releases, use the links at the bottom of the page to see the press releases from that year.
Apr 28, 2013
SAN ANTONIO, TX (April 28, 2013) Doylestown-based representatives and employees of Mission Pharmacal Company celebrate another successful March for Babies, held Sunday, April 28, at Bucks County Community College in Newtown, Pa. The 2013 walk marked the fourth year Mission has been a proud national corporate supporter of the March of Dimes Foundation and a national sponsor of March for Babies, its premier event.
Apr 17, 2013
SAN ANTONIO, TX (April 17, 2013) – Seventy-five years ago, President Franklin D. Roosevelt founded the March of Dimes to “lead, direct and unify” the fight against polio. What President Roosevelt, a polio survivor himself, likely could not have envisioned was that just three-quarters of a century later, polio would be eliminated from the United States. Yet the March of Dimes would continue, shifting from an organization focused on polio vaccine research to becoming a leading nonprofit organization serving mom and baby health.
Mar 27, 2013
SAN ANTONIO, TX (March 27, 2013) – For years, physicians have prescribed Prednisolone (pred NIS oh lone) in a 15 mg/5 mL standard as a rescue medicine to treat severe asthma attacks, especially in children. Unfortunately, its taste has been so unpleasant the patient often vomits after swallowing the medication and resists further usage. Mission Pharmacal Company has recently introduced a new flavored Prednisolone Sodium Phosphate Oral Solution 25mg/5 mL in specific markets in the United States, with plans to have the medicine available nationally as early as April 2013.
Feb 28, 2013
SAN ANTONIO, TX (February 28, 2013) - Mission Pharmacal’s Natalie Sirjuesingh (front row, second from left), vice president of marketing, and members of the company’s sales force at the New York Stock Exchange (NYSE) Closing Bell® on February 28 to officially kick off March for Babies 2013.
Jan 22, 2013
SAN ANTONIO, TX (January 22, 2013) - BINOSTO® (alendronate sodium) Effervescent Tablet for oral solution 70 mg, was named a “Product to Watch” in the January 7, 2013, edition of BioCentury, the Bernstein Report on BioBusiness newsletter. BioCentury is an internationally recognized leader in providing pharmaceutical analysis and data, along with value-added information for biotechnology and pharmaceutical companies.
